In an April Wall Street Journal story, Credit Suisse analyst Catherine Arnold detailed how Bristol-Myers Squibb, Pfizer, and Eli Lilly raised the prices of leukemia, kidney cancer, attention deficit, and erectile function drugs (including Pfizers Viagra...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug firms tired song and dance on reform
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account